Nanotechnology used to destroy and prevent relapse of solid tumor cancers
As people across the globe look forward to longer life expectancies, malignant cancers continue to pose threats to human health. The exploration and development of immunotherapy aims to seek new breakthroughs for the treatment of solid tumors. Although immune checkpoint-based immunotherapy has been shown to have great potential, only a small proportion of patients fully respond to this therapy, and the relevant molecular mechanisms need to be further explored. This delivery method is however complex and inefficient. In a breakthrough development, a team of scientists has formulated a novel vaccine which showed high efficacy in the treatment of solid tumors, achieving complete clearance of solid tumors and inducing long-lasting immune memory. This prevents the relapse of tumor growth that the patient originally presented with and provides immunity against similar tumour types. This was shown through the application of this vaccine on melanoma tumor models.
Materials provided by National University of Singapore, Yong Loo Lin School of Medicine. Note: Content may be edited for style and length.
Source link aaaaa
